Biotech Essentials

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 28.01.2021.

#BioTech
#clinical
#investment
#Genetherapy
#digitalhealth

Healthcare

@emilylmullin shared
On Jan 26, 2021
RT @HelenBranswell: In what turned out to be the last days of her life, @sxbegle worked on a story about the rising incidence of lung cancer in never smokers — the disease that killed her earlier this month. It was Sharon's final story. https://t.co/3BDpWsWIv4
Open
‘But I never smoked’: A growing share of lung cancer cases is turning up in an unexpected population

‘But I never smoked’: A growing share of lung cancer cases is turning up in an unexpected population

Scientists disagree whether the number of lung cancer patients who never smoked is increasing, but the proportion who never did clearly is.

@Dominic_Tyer shared
On Jan 28, 2021
RT @AlderleyPark: Great @pharmaphorum read ft. @RedxPharma's CEO 👉 "Thanks to the new #investment, plus partnerships with @AstraZeneca & @JazzPharma, the company is well positioned to develop two promising #clinical stage drugs in-house, at least until the end of phase 2." https://t.co/R4ByIzznXH
Open
RedX Pharma CEO focuses on pipeline that found Lilly’s rising star

RedX Pharma CEO focuses on pipeline that found Lilly’s rising star

Back in 2017, the UK biotech RedX Pharma had to sell off its prized asset after administrators stepped in to stave off a debt crisis, with Loxo Oncology snapping up the BTK inhibitor for ...

@BIODeutschland shared
On Jan 27, 2021
Secures more than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases https://t.co/jTJgTG0SLQ
Open
GeneQuine Biotherapeutics Secures more than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases

GeneQuine Biotherapeutics Secures more than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases

Proceeds will facilitate development of GeneQuine’s gene therapy pipeline for musculoskeletal disorders and vector platform Lead gene therapy candidate GQ-303, a potentially …

@BIODeutschland shared
On Jan 27, 2021
RT @GeneQuineBio: @GeneQuineBio Secures More Than €9 Million in Series A Financing and Non-Dilutive Funding to Advance #Genetherapy Pipeline for Musculoskeletal Diseases read more: https://t.co/WN1ws8m9ii https://t.co/1kbSsGfkQ4
Open
GeneQuine Biotherapeutics Secures More Than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases [ 26 Jan 2021 ]

GeneQuine Biotherapeutics Secures More Than €9 Million in Series A Financing and Non-Dilutive Funding to Advance Gene Therapy Pipeline for Musculoskeletal Diseases [ 26 Jan 2021 ]

GeneQuine Biotherapeutics is focused on the development of innovative gene therapy drugs for the treatment of osteoarthritis.

@BiotechSweden shared
On Jan 23, 2021
Approval for Bharat Biotech's COVID-19 vaccine Covaxin lacks scientific basis #BioTech via https://t.co/2sI0UxJbpn https://t.co/q0RRFVxBxV
Open
Approval for Bharat Biotech's COVID-19 vaccine Covaxin lacks scientific basis

Approval for Bharat Biotech's COVID-19 vaccine Covaxin lacks scientific basis

The decision to approve a major vaccine without consideration of its efficacy in itself is rather extraordinary to the point of being termed unscientific.

@Biotechnology shared
On Jan 26, 2021
2021 Biopharma Update on the Novel Coronavirus: January 26 https://t.co/9Wwm20QNDe https://t.co/jmTE8ymKp4
Open
2021 Biopharma Update on the Novel Coronavirus: January 26

2021 Biopharma Update on the Novel Coronavirus: January 26

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 26, 2021.

@BiotechSweden shared
On Jan 27, 2021
Covaxin effectively neutralises UK variants: Bharat Biotech #BioTech via https://t.co/2sI0UxJbpn https://t.co/oJvHYilUpd
Open
Covaxin effectively neutralises UK variants: Bharat Biotech

Covaxin effectively neutralises UK variants: Bharat Biotech

India News: India's first indigenous Covid-19 vaccine Covaxin effectively neutralises the deadly and infectious UK variants of SARS-CoV-2 virus, reducing the poss

@Dominic_Tyer shared
On Jan 26, 2021
RT @pharmaphorum: From telehealth to digital trials, customer engagement to healthcare data, @Healthware_intl outlines the key trends expected to shake up #digitalhealth this year! https://t.co/UPCks8jtsL https://t.co/gN9LKsJ8Qe
Open
What we’re expecting in 2021, and beyond…

What we’re expecting in 2021, and beyond…

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year

Read more: Healthcare
weekly 28.01.2021
View archives
Back to home